Annual EPS
-$1.11
+$0.38+25.50%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual earnings per share is -$1.11, with the most recent change of +$0.38 (+25.50%) on December 31, 2023.
- During the last 3 years, CUE annual EPS has risen by +$0.45 (+28.85%).
- CUE annual EPS is now -1088.44% below its all-time high of -$0.09, reached on December 31, 2015.
Performance
CUE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.17
+$0.03+15.00%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly earnings per share is -$0.17, with the most recent change of +$0.03 (+15.00%) on September 30, 2024.
- Over the past year, CUE quarterly EPS has increased by +$0.03 (+15.00%).
- CUE quarterly EPS is now -73.29% below its all-time high of -$0.10, reached on September 30, 2016.
Performance
CUE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$0.91
+$0.07+7.14%
September 30, 2024
Summary
- As of February 20, 2025, CUE TTM earnings per share is -$0.91, with the most recent change of +$0.07 (+7.14%) on September 30, 2024.
- Over the past year, CUE TTM EPS has increased by +$0.07 (+7.14%).
- CUE TTM EPS is now -827.62% below its all-time high of -$0.10, reached on September 30, 2016.
Performance
CUE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CUE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.5% | +15.0% | +7.1% |
| 3 y3 years | +28.9% | +55.3% | +39.3% |
| 5 y5 years | +42.8% | +55.3% | +39.3% |
CUE EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +25.5% | at high | +61.4% | at high | +39.3% |
| 5 y | 5-year | at high | +33.1% | at high | +64.6% | at high | +45.8% |
| alltime | all time | -1088.4% | +42.8% | -73.3% | +72.6% | -827.6% | +58.6% |
Cue Biopharma EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.17(-15.0%) | -$0.91(-7.1%) |
| Jun 2024 | - | -$0.20(-20.0%) | -$0.98(-8.4%) |
| Mar 2024 | - | -$0.25(-13.8%) | -$1.07(-3.6%) |
| Dec 2023 | -$1.11(-25.5%) | -$0.29(+20.8%) | -$1.11(-7.5%) |
| Sep 2023 | - | -$0.24(-17.2%) | -$1.20(-5.5%) |
| Jun 2023 | - | -$0.29(0.0%) | -$1.27(-5.9%) |
| Mar 2023 | - | -$0.29(-23.7%) | -$1.35(-10.0%) |
| Dec 2022 | -$1.49(+5.7%) | -$0.38(+22.6%) | -$1.50(+9.5%) |
| Sep 2022 | - | -$0.31(-16.2%) | -$1.37(-6.8%) |
| Jun 2022 | - | -$0.37(-15.9%) | -$1.47(+2.8%) |
| Mar 2022 | - | -$0.44(+76.0%) | -$1.43(+2.1%) |
| Dec 2021 | -$1.41(-9.6%) | -$0.25(-39.0%) | -$1.40(-7.3%) |
| Sep 2021 | - | -$0.41(+24.2%) | -$1.51(+4.9%) |
| Jun 2021 | - | -$0.33(-19.5%) | -$1.44(-3.4%) |
| Mar 2021 | - | -$0.41(+13.9%) | -$1.49(-4.5%) |
| Dec 2020 | -$1.56 | -$0.36(+5.9%) | -$1.56(-0.6%) |
| Sep 2020 | - | -$0.34(-10.5%) | -$1.57(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$0.38(-20.8%) | -$1.54(-4.9%) |
| Mar 2020 | - | -$0.48(+29.7%) | -$1.62(-3.6%) |
| Dec 2019 | -$1.66(-14.4%) | -$0.37(+19.4%) | -$1.68(-11.1%) |
| Sep 2019 | - | -$0.31(-32.6%) | -$1.89(-14.1%) |
| Jun 2019 | - | -$0.46(-14.8%) | -$2.20(+4.8%) |
| Mar 2019 | - | -$0.54(-6.9%) | -$2.10(+8.8%) |
| Dec 2018 | -$1.94(+72.4%) | -$0.58(-6.5%) | -$1.93(+4.0%) |
| Sep 2018 | - | -$0.62(+72.2%) | -$1.86(+25.4%) |
| Jun 2018 | - | -$0.36(-2.7%) | -$1.48(+11.0%) |
| Mar 2018 | - | -$0.37(-26.8%) | -$1.33(+18.5%) |
| Dec 2017 | -$1.13(+203.4%) | -$0.51(+107.4%) | -$1.13(+48.6%) |
| Sep 2017 | - | -$0.24(+14.0%) | -$0.76(+23.8%) |
| Jun 2017 | - | -$0.21(+31.7%) | -$0.61(+53.7%) |
| Mar 2017 | - | -$0.16(+17.9%) | -$0.40(+68.8%) |
| Dec 2016 | -$0.37(+297.2%) | -$0.14(+40.4%) | -$0.24(+140.4%) |
| Sep 2016 | - | -$0.10 | -$0.10 |
| Dec 2015 | -$0.09 | - | - |
FAQ
- What is Cue Biopharma annual earnings per share?
- What is the all time high annual EPS for Cue Biopharma?
- What is Cue Biopharma annual EPS year-on-year change?
- What is Cue Biopharma quarterly earnings per share?
- What is the all time high quarterly EPS for Cue Biopharma?
- What is Cue Biopharma quarterly EPS year-on-year change?
- What is Cue Biopharma TTM earnings per share?
- What is the all time high TTM EPS for Cue Biopharma?
- What is Cue Biopharma TTM EPS year-on-year change?
What is Cue Biopharma annual earnings per share?
The current annual EPS of CUE is -$1.11
What is the all time high annual EPS for Cue Biopharma?
Cue Biopharma all-time high annual earnings per share is -$0.09
What is Cue Biopharma annual EPS year-on-year change?
Over the past year, CUE annual earnings per share has changed by +$0.38 (+25.50%)
What is Cue Biopharma quarterly earnings per share?
The current quarterly EPS of CUE is -$0.17
What is the all time high quarterly EPS for Cue Biopharma?
Cue Biopharma all-time high quarterly earnings per share is -$0.10
What is Cue Biopharma quarterly EPS year-on-year change?
Over the past year, CUE quarterly earnings per share has changed by +$0.03 (+15.00%)
What is Cue Biopharma TTM earnings per share?
The current TTM EPS of CUE is -$0.91
What is the all time high TTM EPS for Cue Biopharma?
Cue Biopharma all-time high TTM earnings per share is -$0.10
What is Cue Biopharma TTM EPS year-on-year change?
Over the past year, CUE TTM earnings per share has changed by +$0.07 (+7.14%)